CSIMarket


Moderna Inc   (MRNA)
Other Ticker:  
 

Cumulative Moderna Inc 's Quick Ratio for Trailing Twelve Months Period

MRNA's Quick Ratio for Trailing Twelve Months Period and Cash & cash equivalent, Current Liabilities growth


Select the Comparisons : Select the Ratio:

MRNA Quick Ratio for Trailing Twelve Months Period

(Sep 30 2021)
III. Quarter
(Jun 30 2021)
II. Quarter
(Mar 31 2021)
I. Quarter
(Dec 31 2020)
IV. Quarter
(Sep 30 2020)
III. Quarter
Y / Y Current Liabilities Growth 575.71 % 5368.71 % 6176.76 % 42480.85 % 15523 %
Y / Y Cash & cash equivalent Growth 171.83 % 194.07 % 535.21 % 9215116 % 121605.13 %
Quick Ratio for Trailing Twelve Months Period 0.92 1.02 1.27 1.92 4.05
Total Ranking # 1852 # 1887 # 1610 # 1205 # 585
Seq. Current Liabilities Growth 12.64 % 4.65 % 92.48 % 197.84 % 811.59 %
Seq. Cash & cash equivalent Growth 11.46 % 3.3 % 67.87 % 40.63 % 20.58 %


Quick Ratio for Trailing Twelve Months Period Comment
On the trailing twelve months basis Due to increase in Current Liabilities in the III. Quarter to $9,957 millions, average cumulative Quick Ratio for Trailing Twelve Months Period decreased to 0.92 below Moderna Inc average Quick Ratio for Trailing Twelve Months Period.
Quick Ratio for Trailing Twelve Months Period is the average cumulative value over the last four quarters.

Among companies operatig within Biotechnology & Pharmaceuticals industry 167 other companies have achieved higher Quick Ratio for Trailing Twelve Months Period than Moderna Inc . While Quick Ratio for Trailing Twelve Months Period overall ranking has improved so far to 1852, from total ranking in previous quarter at 1887.

What is Quick Ratio?
Learn more about MRNA
Quick Ratio MRNA in the most recent quarter
Quick Ratio for Trailing Twelve Months Period Company Ranking
Within: No.
Industry # 168
Sector # 671
S&P 500 # 1841


Quick Ratio for Trailing Twelve Months Period Statistics
High Average Low
12.46 2.32 0.05
(Jun 30 2020)   (June 30. 2013)




Companies with similar average Quick Ratio for Trailing Twelve Months Period for 12 months ending Sep 30 2021, within Biotechnology & Pharmaceuticals Industry Quick Ratio for Trailing Twelve Months Period
Armata Pharmaceuticals Inc   2.38 
Apollo Endosurgery inc   2.31 
La Jolla Pharmaceutical Company  2.30 
Regenerx Biopharmaceuticals inc   2.29 
Precipio inc   2.27 
Adma Biologics Inc   2.25 
Wave Life Sciences Ltd   2.16 
Fate Therapeutics Inc   2.14 
Fulgent Genetics Inc   2.12 
Urovant Sciences Ltd   2.10 
Aptevo Therapeutics Inc   2.08 
Cannabics Pharmaceuticals Inc   2.06 
Bio techne Corp  2.04 
Vitality Biopharma Inc   2.03 
Biontech Se  2.00 
Blue Biofuels Inc   1.98 
Aerie Pharmaceuticals Inc   1.94 
Neuronetics Inc   1.89 
Procyon Corp  1.88 
Immunitybio inc   1.83 
Axon Enterprise inc   1.79 
Eyenovia inc   1.67 
Chromadex Corporation  1.64 
Biocryst Pharmaceuticals Inc  1.59 
Petvivo Holdings Inc  1.56 
Erytech Pharma S a   1.51 
Iterum Therapeutics Plc  1.49 
Biorestorative Therapies Inc   1.33 
Surgalign Holdings Inc   1.33 
Emergent Biosolutions Inc   1.32 


       
Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

PLMI's Profile

Stock Price

PLMI's Financials

Business Description

Fundamentals

Charts & Quotes

PLMI's News

Suppliers

PLMI's Competitors

Customers & Markets

Economic Indicators

PLMI's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Cryptocurrencies

Sectors & Industries

Commodities

Currencies

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.    Copyright © 2021 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071